An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the <i>UBE3A-AS</i> transcriptScott V. Dindot, Jill L. Silverman, Allyson Berent et al.|Science Translational Medicine|2023Cited by 95
TPI deficiency: A case report and review of the literatureFernando Scaglia, Monika Weisz‐Hubshman, Vittoria Rossi et al.|Molecular Genetics and Metabolism|2025Cited by 2